Evidence map›Paper›PMID 26340408›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2015

Novel Insertion Mutation in KCNJ5 Channel Produces Constitutive Aldosterone Release From H295R Cells.

Iris Hardege, Shengxin Xu, Richard D Gordon, Andrew J Thompson, Nichola Figg, Michael Stowasser, Ruth Murrell-Lagnado, Kevin M O'Shaughnessy

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cardiovascular and metabolic characters ofFrontiers in endocrinology · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Targeted disruption of theClinical science (London, England : 1979) · 2018
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Iris HardegeDivisions of Experimental Medicine and Immunotherapeutics (I.H., K.M.O.) and Cardiovascular Medicine (N.F.), Department of Medicine, and Department of Pharmacology (A.J.T., R.M.-L.), University of Cambridge, Cambridge CB2 2QQ, United Kingdom; and Endocrine Hypertension Research Centre (S.X., R.D.G., M.S.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4072, Australia.
Shengxin XuDivisions of Experimental Medicine and Immunotherapeutics (I.H., K.M.O.) and Cardiovascular Medicine (N.F.), Department of Medicine, and Department of Pharmacology (A.J.T., R.M.-L.), University of Cambridge, Cambridge CB2 2QQ, United Kingdom; and Endocrine Hypertension Research Centre (S.X., R.D.G., M.S.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4072, Australia.
Richard D GordonDivisions of Experimental Medicine and Immunotherapeutics (I.H., K.M.O.) and Cardiovascular Medicine (N.F.), Department of Medicine, and Department of Pharmacology (A.J.T., R.M.-L.), University of Cambridge, Cambridge CB2 2QQ, United Kingdom; and Endocrine Hypertension Research Centre (S.X., R.D.G., M.S.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4072, Australia.
Andrew J ThompsonDivisions of Experimental Medicine and Immunotherapeutics (I.H., K.M.O.) and Cardiovascular Medicine (N.F.), Department of Medicine, and Department of Pharmacology (A.J.T., R.M.-L.), University of Cambridge, Cambridge CB2 2QQ, United Kingdom; and Endocrine Hypertension Research Centre (S.X., R.D.G., M.S.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4072, Australia.
Nichola FiggDivisions of Experimental Medicine and Immunotherapeutics (I.H., K.M.O.) and Cardiovascular Medicine (N.F.), Department of Medicine, and Department of Pharmacology (A.J.T., R.M.-L.), University of Cambridge, Cambridge CB2 2QQ, United Kingdom; and Endocrine Hypertension Research Centre (S.X., R.D.G., M.S.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4072, Australia.
Michael StowasserDivisions of Experimental Medicine and Immunotherapeutics (I.H., K.M.O.) and Cardiovascular Medicine (N.F.), Department of Medicine, and Department of Pharmacology (A.J.T., R.M.-L.), University of Cambridge, Cambridge CB2 2QQ, United Kingdom; and Endocrine Hypertension Research Centre (S.X., R.D.G., M.S.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4072, Australia.
Ruth Murrell-LagnadoDivisions of Experimental Medicine and Immunotherapeutics (I.H., K.M.O.) and Cardiovascular Medicine (N.F.), Department of Medicine, and Department of Pharmacology (A.J.T., R.M.-L.), University of Cambridge, Cambridge CB2 2QQ, United Kingdom; and Endocrine Hypertension Research Centre (S.X., R.D.G., M.S.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4072, Australia.
Kevin M O'ShaughnessyDivisions of Experimental Medicine and Immunotherapeutics (I.H., K.M.O.) and Cardiovascular Medicine (N.F.), Department of Medicine, and Department of Pharmacology (A.J.T., R.M.-L.), University of Cambridge, Cambridge CB2 2QQ, United Kingdom; and Endocrine Hypertension Research Centre (S.X., R.D.G., M.S.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4072, Australia.
University of Cambridge · GBThe University of Queensland · AU

Funding

British Heart Foundation FS/12/78/29875British Heart Foundation PG/13/39/30293British Heart Foundation PG/13/89/30577
6 · The paper itself

Abstract

Primary aldosteronism accounts for 5%-10% of hypertension and in a third of cases is caused by autonomous aldosterone production by adenomas (APA). Somatic mutations in the potassium channel encoded by KCNJ5 have been detected in surgically removed APAs. To better understand the role of these mutations, we resequenced the KCNJ5 channel in a large Australian primary aldosteronism cohort. KCNJ5 mutations were detected in 37 APAs (45% of the cohort), including previously reported E145Q (n = 3), G151R (n = 20), and L168R (n = 13) mutations. In addition, we found a novel 12-bp in-frame insertion mutation (c.414-425dupGCTTTCCTGTTC, A139_F142dup) that duplicates the AFLF sequence in the pore helix upstream of the selectivity filter. Expressed in Xenopus oocytes, the A139_F142dup mutation depolarized the oocytes and produced a G-protein-sensitive Na(+) current with altered K(+) selectivity and loss of inward rectification but retained Ba(2+) sensitivity. Transfected into H295R cells, A139_F142dup increased basal aldosterone release 2.3-fold over the wild type. This was not increased further by incubation with angiotensin II. Although the A139_F142dup mutant trafficked to the plasma membrane of H295R cells, it showed reduced tetramer stability and surface expression compared with the wild-type channel. This study confirms the frequency of somatic KCNJ5 mutations in APAs and the novel mutation identified (A139_F142dup) extend the phenotypic range of the known KCNJ5 APA mutations. Being located in the pore helix, it is upstream of the previously reported mutations and shares some features in common with selectivity filter mutants but additionally demonstrates insensitivity to angiotensin II and decreased channel stability.

Indexed as

Mutagenesis, InsertionalAldosteroneAmino Acid SequenceAngiotensinsAnimalsBase SequenceCell LineDNA Mutational AnalysisElectrophysiological PhenomenaG Protein-Coupled Inwardly-Rectifying Potassium ChannelsHumansMaleMiddle AgedMolecular Sequence DataMutationProtein StabilityAldosteroneAngiotensinsG Protein-Coupled Inwardly-Rectifying Potassium ChannelsKCNJ5 protein, human

Identifiers

PMID26340408
PMCPMC5414677
OpenAlexW2130202558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.